Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
- 1 January 2010
- journal article
- conference paper
- Published by Elsevier in Neuropharmacology
- Vol. 58 (1) , 69-77
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Brain Oxytocin: A Key Regulator of Emotional and Social Behaviours in Both Females and MalesJournal of Neuroendocrinology, 2008
- Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like EffectsNeuropsychopharmacology, 2007
- Nonpeptide oxytocin agonistsDrugs of the Future, 2006
- Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by OxytocinNeuropsychopharmacology, 2005
- 1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.Journal of Medicinal Chemistry, 1995
- Central functions of oxytocinNeuroscience & Biobehavioral Reviews, 1991
- Oxytocin acts as an antidepressant in two animal models of depressionLife Sciences, 1987
- Psychotropic properties of oxytocinNeuroscience and Behavioral Physiology, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Hormones in the treatment of psychoses.BMJ, 1972